Infant Development — Turkish Version of Infant Movement Motivation Questionnaire
Citation(s)
Caçola PM, Gabbard C, Montebelo MI, Santos DC Further Development and Validation of the Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS). Phys Ther. 2015 Jun;95(6):901-23. doi: 10.2522/ptj.20140011. Epub 2014 Dec 18.
Doralp S, Bartlett D Infant Movement Motivation Questionnaire: development of a measure evaluating infant characteristics relating to motor development in the first year of life. Infant Behav Dev. 2014 Aug;37(3):326-33. doi: 10.1016/j.infbeh.2014.04.002. Epub 2014 May 28.
Doralp S, Bartlett DJ Environmental opportunities questionnaire: development of a measure of the environment supporting early motor development in the first year of life. Disabil Rehabil. 2013 Sep;35(20):1692-7. doi: 10.3109/09638288.2012.751133. Epub 2013 Jan 25.
Turkish Validity and Reliability Study of Infant Movement Motivation Questionnaire
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
